Breast cancer is a heterogeneous disease which can be stratified into different clinical subtypes based on their biomarker expression (ER-estrogen receptor, HER2-human epidermal growth factor, and PR-progesterone receptor). This evidence concerns the gene ESR1 and breast cancer.